Monika Tandon

Title: Monika Tandon: Innovator in Osteoarthritis Treatment

Introduction

Monika Tandon is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoarthritis pain. Her innovative work has led to the development of a unique compound that addresses a common yet debilitating condition.

Latest Patents

Monika Tandon holds 1 patent for her invention of an mPGES-1 inhibitor for the treatment of osteoarthritis pain. This invention relates to a microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor that can be orally administered to treat moderate osteoarthritis pain in subjects. The patent also encompasses pharmaceutical compositions that include the mPGES-1 inhibitor and outlines processes for preparing these compositions.

Career Highlights

Monika Tandon is associated with Ichnos Sciences SA, where she continues to advance her research and development efforts. Her work is pivotal in creating effective treatments that improve the quality of life for individuals suffering from osteoarthritis.

Collaborations

Monika collaborates with talented professionals in her field, including Sumit Sant and Neelima Khairatkar-Joshi. These collaborations enhance the innovative potential of her projects and contribute to the advancement of medical science.

Conclusion

Monika Tandon's contributions to the field of osteoarthritis treatment exemplify her dedication to innovation and improving patient care. Her work not only highlights her expertise but also underscores the importance of research in developing effective therapeutic solutions.